论文部分内容阅读
观察了不同肿瘤患者血清超弱发光变化。结果表明，肿瘤患者血清超弱发光强度显著高于正常对照组，１０种不同类型的肿瘤，超弱发光水平增长约２５％～５０％。葡萄胎正负增长各半。血清中加入生理盐水，不影响正常发光活性。认为血清超弱发光可作为肿瘤诊断的指标。
Serum ultraweak luminescence changes were observed in patients with different tumors. The results showed that the ultra-weak luminescence intensity of tumor patients was significantly higher than that of the normal control group. In 10 different types of tumors, the ultraweak luminescence increased by approximately 25% to 50%. The proportion of hydatidiform moles increases by half. The addition of physiological saline to the serum does not affect normal luminescence activity. It is considered that serum superweak luminescence can be used as an indicator of tumor diagnosis.